Annual Current Liabilities
$180.70 K
-$9.58 M-98.15%
June 30, 2024
Summary
- As of February 22, 2025, ESLA annual total current liabilities is $180.70 thousand, with the most recent change of -$9.58 million (-98.15%) on June 30, 2024.
- During the last 3 years, ESLA annual current liabilities has risen by +$180.70 thousand (+100.00%).
- ESLA annual current liabilities is now -98.15% below its all-time high of $9.76 million, reached on June 1, 2023.
Performance
ESLA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.99 M
+$2.81 M+1554.07%
September 30, 2024
Summary
- As of February 22, 2025, ESLA quarterly total current liabilities is $2.99 million, with the most recent change of +$2.81 million (+1554.07%) on September 30, 2024.
- Over the past year, ESLA quarterly current liabilities has increased by +$2.59 million (+649.66%).
- ESLA quarterly current liabilities is now -82.70% below its all-time high of $17.28 million, reached on September 30, 2023.
Performance
ESLA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ESLA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.2% | +649.7% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | +100.0% | - |
ESLA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.2% | -100.0% | -82.7% | +2058.1% |
| 5 y | 5-year | -98.2% | -100.0% | -82.7% | +2058.1% |
| alltime | all time | -98.2% | -100.0% | -82.7% | +2058.1% |
Estrella Immunopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.99 M(+1554.1%) |
| Jun 2024 | $180.70 K | $180.70 K(+30.5%) |
| Mar 2024 | - | $138.50 K(-65.3%) |
| Dec 2023 | - | $398.70 K(-97.7%) |
| Sep 2023 | - | $17.28 M(+77.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $9.76 M(+116.9%) |
| Jun 2023 | $9.76 M(+930.8%) | - |
| Dec 2022 | - | $4.50 M |
| Jun 2022 | $946.70 K(>+9900.0%) | - |
| Jun 2021 | $0.00 | - |
FAQ
- What is Estrella Immunopharma annual total current liabilities?
- What is the all time high annual current liabilities for Estrella Immunopharma?
- What is Estrella Immunopharma annual current liabilities year-on-year change?
- What is Estrella Immunopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly current liabilities year-on-year change?
What is Estrella Immunopharma annual total current liabilities?
The current annual current liabilities of ESLA is $180.70 K
What is the all time high annual current liabilities for Estrella Immunopharma?
Estrella Immunopharma all-time high annual total current liabilities is $9.76 M
What is Estrella Immunopharma annual current liabilities year-on-year change?
Over the past year, ESLA annual total current liabilities has changed by -$9.58 M (-98.15%)
What is Estrella Immunopharma quarterly total current liabilities?
The current quarterly current liabilities of ESLA is $2.99 M
What is the all time high quarterly current liabilities for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly total current liabilities is $17.28 M
What is Estrella Immunopharma quarterly current liabilities year-on-year change?
Over the past year, ESLA quarterly total current liabilities has changed by +$2.59 M (+649.66%)